Goodnow joins Garvan as deputy director


Monday, 02 February, 2015

Professor Chris Goodnow has joined the Garvan Institute of Medical Research as deputy director. He has also accepted The Bill and Patricia Ritchie Foundation Chair.

At Garvan he will head the Immunogenomics Group to investigate the underlying genetic causes of immune disorders, particularly autoimmune diseases.

Goodnow, who is current president of the Australasian Society for Immunology, leaves the Division of Immunology at the John Curtin School of Medical Research, Australian National University (ANU). He joined ANU in 1997 as Professor and director of the Medical Genome Centre, leading its development into a Major National Research Facility, the Australian Phenomics Facility.

While at Garvan, Goodnow will continue to pursue his interest in how the immune system makes its decisions, in particular how it distinguishes between ‘self’ and ‘non-self’.

He will take full advantage of the powerful whole genome sequencers at The Kinghorn Cancer Centre as well as in-house capacity to engineer mice with specific genetic mutations.

At the same time, he hopes to establish a network of people working in the field of autoimmunity to combine clinical expertise with genomic and molecular immunology research.

Related News

Scientists find new driver of ovarian cancer spread

A cell surface receptor known as F2R could serve as both a diagnostic marker for ovarian cancer...

Hormone therapy shifts body proteins to match gender identity

Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...

Targeting 'molecular bodyguards' weakens prostate cancer cells

Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd